Alka-Seltzer Plus line extension
This article was originally published in The Tan Sheet
Executive Summary
New Alka-Seltzer Plus Nose & Throat backed by TV ad featuring tagline "totally focused relief," as well as Nov. 3 FSI drop, in-store displays, Bayer says. Ad campaign, designed by BBDO (Chicago), broke in October. On shelves now, Nose & Throat contains four active ingredients - acetaminophen 250 mg, chlorpheniramine maleate 2 mg, dextromethorphan hydrobromide 10 mg, phenylephrine hydrochloride 5 mg - to provide "more comprehensive relief of your worst cold symptoms," such as runny nose, nasal congestion, sore throat and cough. Effervescent tablets are available in citrus blend flavor; 20-count box retails for roughly $5.99. Also, Bayer has brought back "classic seltzer flavor" for Alka-Seltzer Plus Cold; revamped taste hit shelves in October...
You may also be interested in...
Bayer Focuses On OTCs As Consumer Care Streamlining Continues
Bayer AG reaffirmed its commitment to its nonprescription products portfolio as the firm continues to streamline its consumer care division
Abbott's ‘Bedrock Of Good Health’ Nutritionals Business Faces Mounting Infant Formula Litigation
Nutritional product business had 5.1% Q1 sales growth and is like Abbott’s other segments, “super well-aligned to the global demographics and trends in health care,” says CEO Ford. But as it defends complaints of damages from powder formulas made at facility found with unsafe levels of bacterial contaminants, Abbott’s also targeted in litigation alleging failure to warn about risk of infants born prematurely developing necrotizing enterocolitis if fed cow’s milk-based formula.
‘Core Pillars’ Of Safety And Innovation Take Center Stage In FDA Reports
The US FDA has issued a pair of reports focused on device safety and innovation. The reports describe recent steps the agency has taken to improve in the two areas, and what it plans to do next.